Cessatech AS (XSAT:CESSA) Cash-to-Debt : No Debt ⁽¹⁾ (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Cessatech AS Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Cessatech AS's cash to debt ratio for the quarter that ended in Mar. 2024 was No Debt ⁽¹⁾.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Cessatech AS could pay off its debt using the cash in hand for the quarter that ended in Mar. 2024.

(1) Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for Cessatech AS's Cash-to-Debt or its related term are showing as below:

XSAT:CESSA' s Cash-to-Debt Range Over the Past 10 Years
Min: No Debt Med: No Debt Max: No Debt
Current: No Debt

During the past 4 years, Cessatech AS's highest Cash to Debt Ratio was No Debt. The lowest was No Debt. And the median was No Debt.

XSAT:CESSA's Cash-to-Debt is ranked better than
99.8% of 1489 companies
in the Biotechnology industry
Industry Median: 6.91 vs XSAT:CESSA: No Debt

Cessatech AS Cash-to-Debt Historical Data

The historical data trend for Cessatech AS's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Cessatech AS Cash-to-Debt Chart

Cessatech AS Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

No Debt

Cessatech AS Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash-to-Debt	Get a 7-Day Free Trial										No Debt	No Debt	No Debt	No Debt	No Debt

Competitive Comparison of Cessatech AS's Cash-to-Debt

For the Biotechnology subindustry, Cessatech AS's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cessatech AS's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cessatech AS's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Cessatech AS's Cash-to-Debt falls into.

Cessatech AS Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Cessatech AS's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cessatech AS had no debt ⁽¹⁾.

Cessatech AS's Cash to Debt Ratio for the quarter that ended in Mar. 2024 is calculated as:

Cessatech AS had no debt ⁽¹⁾.

Cessatech AS (XSAT:CESSA) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Cessatech AS Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Cessatech AS's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Cessatech AS (XSAT:CESSA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cessatech AS (XSAT:CESSA) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

8GN:Germany

Address

Kanonbadsvej 2, Copenhagen, DNK, 1437

Website

https://www.cessatech.com

Cessatech AS is a pharmaceutical company committed to developing and commercializing evidence-based and innovative medicines for children for the treatment of paediatric acute pain. Its lead asset (CT001) is an analgesic nasal spray for the treatment of acute and planned painful procedures in children.

Cessatech AS (XSAT:CESSA) Headlines

No Headlines

Cessatech AS (XSAT:CESSA) Cash-to-Debt : No Debt (1) (As of Mar. 2024)